JD Health International (HKSE:06618) Capex-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

JD Health International's Capital Expenditure for the six months ended in Dec. 2023 was HK$-31.78 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$28,897.21 Mil.

Hence, JD Health International's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.00.

JD Health International Capex-to-Revenue Historical Data

The historical data trend for JD Health International's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JD Health International Capex-to-Revenue Chart

JD Health International Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

Get a 7-Day Free Trial

0.02

0.05

JD Health International Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial							0.03	-	0.09	-	-

Competitive Comparison of JD Health International's Capex-to-Revenue

For the Medical Care Facilities subindustry, JD Health International's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JD Health International's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where JD Health International's Capex-to-Revenue falls into.

JD Health International Capex-to-Revenue Calculation

JD Health International's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-75.835)	/	58549.919
	=	0.00

JD Health International's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-31.78)	/	28897.206
	=	0.00

JD Health International (HKSE:06618) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

JD Health International Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of JD Health International's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines